4//SEC Filing
Hack Andrew A. F. 4
Accession 0000950170-24-136230
CIK 0001861560other
Filed
Dec 12, 7:00 PM ET
Accepted
Dec 13, 4:30 PM ET
Size
6.1 KB
Accession
0000950170-24-136230
Insider Transaction Report
Form 4
Nuvalent, Inc.NUVL
Hack Andrew A. F.
Director
Transactions
- Sale
Class A Common Stock
2024-12-11$88.00/sh−1,250,000$110,000,000→ 1,447,267 total(indirect: See footnotes)
Holdings
- 2,499
Class A Common Stock
Footnotes (2)
- [F1]Represents shares of Class A Common Stock held directly by Bain Capital Life Sciences Fund II, L.P. ("BCLS Fund II"), BCIP Life Sciences Associates, LP ("BCIPLS") and BCLS II Investco, LP ("BCLS II Investco" and, together with BCLS Fund II and BCIPLS, the "Bain Capital Life Sciences Entities").
- [F2]Bain Capital Life Sciences Investors, LLC ("BCLSI") is the ultimate general partner of each of BCLS Fund II and BCLS II Investco and governs the investment strategy and decision-making process with respect to investments held by BCIPLS. Dr. Hack is a Partner of BCLSI. By virtue of the relationships described in this footnote, Dr. Hack may be deemed to share voting and dispositive power with respect to the securities held by the Bain Capital Life Sciences Entities. Dr. Hack disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein.
Documents
Issuer
Nuvalent, Inc.
CIK 0001861560
Entity typeother
Related Parties
1- filerCIK 0001657434
Filing Metadata
- Form type
- 4
- Filed
- Dec 12, 7:00 PM ET
- Accepted
- Dec 13, 4:30 PM ET
- Size
- 6.1 KB